Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Current Rheumatology Reports
|
May 5, 2018
New Trials in Lupus and where Are we Going
Aikaterini Thanou, Joan T Merrill
Current Rheumatology Reports
|
January 29, 2021
SARS-CoV-2 and Systemic Lupus Erythematosus
Aikaterini Thanou, Amr H Sawalha
Nature Reviews. Rheumatology
|
October 9, 2013
Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys
Aikaterini Thanou, Joan T Merrill
Current Rheumatology Reports
|
April 23, 2013
Top 10 things to know about lupus activity measures
Aikaterini Thanou, Joan T Merrill
Biologics : Targets & Therapy
|
March 9, 2011
An update on belimumab for the treatment of lupus
Aikaterini Thanou-Stavraki, Amr H Sawalha
Seminars in Arthritis and Rheumatism
|
August 24, 2007
Primary Sjogren's syndrome: current and prospective therapies
Aikaterini Thanou-Stavraki, Judith A James
Rheumatology (Oxford, England)
|
April 15, 2014
How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index
Aikaterini Thanou, Eliza Chakravarty, Judith A James, et al.
Lupus Science & Medicine
|
November 15, 2014
Which outcome measures in SLE clinical trials best reflect medical judgment?
Aikaterini Thanou, Eliza Chakravarty, Judith A James, et al.
Journal of Autoimmunity
|
February 25, 2021
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers
Aikaterini Thanou, Eldon Jupe, Mohan Purushothaman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 29, 2011
Clarithromycin in adult-onset still's disease: a potentially useful therapeutic
Aikaterini Thanou-Stavraki, Teresa Aberle, Ivona Aksentijevich, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Current Rheumatology Reports
|
May 5, 2018
New Trials in Lupus and where Are we Going
Aikaterini Thanou, Joan T Merrill
Current Rheumatology Reports
|
January 29, 2021
SARS-CoV-2 and Systemic Lupus Erythematosus
Aikaterini Thanou, Amr H Sawalha
Nature Reviews. Rheumatology
|
October 9, 2013
Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys
Aikaterini Thanou, Joan T Merrill
Current Rheumatology Reports
|
April 23, 2013
Top 10 things to know about lupus activity measures
Aikaterini Thanou, Joan T Merrill
Biologics : Targets & Therapy
|
March 9, 2011
An update on belimumab for the treatment of lupus
Aikaterini Thanou-Stavraki, Amr H Sawalha
Seminars in Arthritis and Rheumatism
|
August 24, 2007
Primary Sjogren's syndrome: current and prospective therapies
Aikaterini Thanou-Stavraki, Judith A James
Rheumatology (Oxford, England)
|
April 15, 2014
How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index
Aikaterini Thanou, Eliza Chakravarty, Judith A James, et al.
Lupus Science & Medicine
|
November 15, 2014
Which outcome measures in SLE clinical trials best reflect medical judgment?
Aikaterini Thanou, Eliza Chakravarty, Judith A James, et al.
Journal of Autoimmunity
|
February 25, 2021
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers
Aikaterini Thanou, Eldon Jupe, Mohan Purushothaman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 29, 2011
Clarithromycin in adult-onset still's disease: a potentially useful therapeutic
Aikaterini Thanou-Stavraki, Teresa Aberle, Ivona Aksentijevich, et al.
Page
of 3